0001209191-23-023108.txt : 20230404
0001209191-23-023108.hdr.sgml : 20230404
20230404211445
ACCESSION NUMBER: 0001209191-23-023108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230401
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krishnan Mahesh
CENTRAL INDEX KEY: 0001866746
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 23800959
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER NAME:
FORMER CONFORMED NAME: Krishan Mahesh
DATE OF NAME CHANGE: 20210610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHINOOK THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH, SUITE 900
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-485-7051
MAIL ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH, SUITE 900
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH, INC.
DATE OF NAME CHANGE: 20111107
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-01
0
0001435049
CHINOOK THERAPEUTICS, INC.
KDNY
0001866746
Krishnan Mahesh
C/O CHINOOK THERAPEUTICS, INC.
400 FAIRVIEW AVE. NO., 9TH FLOOR
SEATTLE
WA
98109
1
0
0
0
1
Common Stock
2023-04-01
4
M
0
2199
A
2199
D
Common Stock
2023-04-04
4
S
0
924
23.01
D
1275
D
Restricted Stock Units
2023-04-01
4
M
0
2199
0.00
D
2025-04-04
Common Stock
2199
4401
D
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated February 10, 2023.
Each RSU represents a contingent right to receive one share of Issuer's common stock.
The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on April 1, 2023, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Kirk Schumacher, Attorney-in-Fact
2023-04-04